Fund comparison · from official SEC filings
BIB vs IBRN: how much do they overlap?
ProShares Ultra Nasdaq Biotechnology and iShares Neuroscience and Healthcare ETF
Holdings overlap9%of assets, by weight Shared positions33of 259 / 84 holdings BIB expense ratio0.95%net, per year IBRN expense ratio0.47%net, per year Shared holdings
X
XENEXENON PHARMACEUTICALS INC
0.25%
4.41%
A
AXSMAXSOME THERAPEUTICS INC
0.67%
4.23%
A
ARWRARROWHEAD PHARMACEUTICALS IN
0.61%
4.06%
A
ALKSALKERMES PLC
0.39%
3.87%
2
260CENTESSA PHARMACEUTICALS-ADR
0.27%
3.64%
A
ARGXARGENX SE - ADR
1.33%
3.58%
P
PTCTPTC THERAPEUTICS INC
0.34%
3.40%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.89%
3.39%
B
BIIBBIOGEN INC
1.61%
3.38%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.28%
3.38%
P
PRAXPRAXIS PRECISION MEDICINES I
0.54%
3.37%
A
ACAACADIA PHARMACEUTICALS INC
0.21%
3.33%
D
DNLIDENALI THERAPEUTICS INC
0.19%
2.60%
S
SUPNSUPERNUS PHARMACEUTICALS INC
0.15%
2.56%
E
EWTXEDGEWISE THERAPEUTICS INC
0.20%
2.33%
D
DYNDYNE THERAPEUTICS INC
0.18%
2.18%
S
SRPTSAREPTA THERAPEUTICS INC
0.10%
2.04%
T
TSHATAYSHA GENE THERAPIES INC
0.09%
1.41%
R
RAPPRAPPORT THERAPEUTICS INC
0.11%
0.95%
A
ANNXANNEXON INC
0.04%
0.74%
P
PRTAPROTHENA CORP PLC
0.03%
0.47%
S
SLDBSOLID BIOSCIENCES INC
0.03%
0.43%
D
DSGNDESIGN THERAPEUTICS INC
0.03%
0.42%
R
RGNXREGENXBIO INC
0.02%
0.40%
V
VNDAVANDA PHARMACEUTICALS INC
0.02%
0.38%
Only in BIB
I
IQMMPROSHARES GENIUS MNY MKT ETF
7.57%
G
GILDGILEAD SCIENCES INC
5.19%
V
VRTXVERTEX PHARMACEUTICALS INC
5.18%
A
AMGNAMGEN INC
4.99%
R
REGNREGENERON PHARMACEUTICALS
3.57%
?
—Repurchase Agreement
3.50%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.24%
R
RVMDREVOLUTION MEDICINES INC
1.74%
I
ILMNILLUMINA INC
1.39%
U
UTHRUNITED THERAPEUTICS CORP
1.36%
R
RPRXROYALTY PHARMA PLC- CL A
1.34%
I
INSMINSMED INC
1.29%
R
ROIVROIVANT SCIENCES LTD
1.20%
I
INCYINCYTE CORP
1.08%
V
VTRSVIATRIS INC
1.05%
M
MRNAMODERNA INC
1.04%
G
GHGUARDANT HEALTH INC
0.95%
A
AGPXXINVESCO GVT & AGNCY-INST
0.90%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.81%
A
ASNDASCENDIS PHARMA A/S
0.77%
S
SMMTSUMMIT THERAPEUTICS INC
0.76%
E
EXELEXELIXIS INC
0.73%
B
BBIOBRIDGEBIO PHARMA INC
0.72%
M
MEDPMEDPACE HOLDINGS INC
0.71%
Only in IBRN
B
BISXXBCF INSTITUTIONAL-SL AGNCY
7.89%
D
DNTHDIANTHUS THERAPEUTICS INC
3.12%
?
—CATALYST PHARMACEUTICALS, INC.
3.03%
A
AXGNAXOGEN INC
2.15%
3
326030SK BIOPHARMACEUTICALS CO LTD
1.88%
H
HLBBFH LUNDBECK A/S
1.77%
C
CAPRCAPRICOR THERAPEUTICS INC
1.61%
B
BRCTFBIOARCTIC AB
1.26%
B
BHVNBIOHAVEN LTD
1.20%
N
NURPFNEUREN PHARMACEUTICALS LTD
0.97%
T
TDVXFDYNAVOX GROUP AB
0.86%
D
DRUGBRIGHT MINDS BIOSCIENCES INC
0.84%
I
IDRSFIDORSIA LTD
0.80%
A
ANROALTO NEUROSCIENCE INC
0.72%
S
SNBIFSANBIO CO LTD
0.69%
I
IARTINTEGRA LIFESCIENCES HOLDING
0.69%
M
MDCLFMEDINCELL SA
0.60%
L
LBRXLB PHARMACEUTICALS INC
0.58%
B
BWAYBRAINSWAY LTD-ADR
0.55%
C
CBLLCERIBELL INC
0.48%
2
2190ZYLOX-TONBRIDGE MEDICAL TE-H
0.47%
4
4588ONCOLYS BIOPHARMA INC
0.45%
R
RLMDRELMADA THERAPEUTICS INC
0.45%
2
2172MICROPORT NEUROSCIENTIFIC CO
0.43%
N
NPCENEUROPACE INC
0.42%
Hold BIB and IBRN together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.